{
    "2020-04-09": [
        [
            {
                "time": "",
                "original_text": "智飞生物重磅品种就要批了 新政之下还有哪些重磅新药将获批？",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重磅品种",
                        "新政",
                        "新药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "招商证券：三大方面深度解析血制品行业(个股分析)",
                "features": {
                    "keywords": [
                        "招商证券",
                        "血制品",
                        "行业分析",
                        "个股分析"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "血制品"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【东北医药崔洁铭/马千里】天坛生物（600161）年报点评：公司业绩稳健增长，血液制品需求旺盛",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "年报点评",
                        "业绩增长",
                        "血液制品",
                        "需求旺盛"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "血液制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}